Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DosOp: MDMA-Assisted Therapy for PTSD in U.S. Veterans
NCT06418178Phase 2Recruiting
- Sponsor
- James J. Peters Veterans Affairs Medical Center
- Start
- Jun 2025
- Primary completion
- Oct 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of midomafetamine in post-traumatic stress disorder (PTSD), sponsored by James J. Peters Veterans Affairs Medical Center. Started Jun 2025; status: recruiting.
02
Drugs
midomafetamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT06418178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06418178.